142 related articles for article (PubMed ID: 33945927)
1. A study of tryptophan, kynurenine and serotonin transporter in first-episode drug-naïve major depressive disorder.
Chiu YC; Yang BH; Yang KC; Liu MN; Hu LY; Liou YJ; Chan LY; Chou YH
Psychiatry Res Neuroimaging; 2021 Jun; 312():111296. PubMed ID: 33945927
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study.
Yang KC; Liu MN; Liou YJ; Hu LY; Yang BH; Chou YH
J Psychiatr Res; 2021 Mar; 135():174-180. PubMed ID: 33493946
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.
Hughes MM; Carballedo A; McLoughlin DM; Amico F; Harkin A; Frodl T; Connor TJ
Brain Behav Immun; 2012 Aug; 26(6):979-87. PubMed ID: 22683764
[TBL] [Abstract][Full Text] [Related]
5. Amygdala substructure volumes and serotonin transporter in first-episode, drug- naïve major depressive disorder: A pilot study.
Chen CW; Chou YH; Liou YJ; Yang KC; Hu LY; Hsieh WC; Liu MN
J Psychiatr Res; 2023 Apr; 160():210-216. PubMed ID: 36857985
[TBL] [Abstract][Full Text] [Related]
6. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
7. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
Ruhé HG; Booij J; Reitsma JB; Schene AH
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
[TBL] [Abstract][Full Text] [Related]
8. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
[TBL] [Abstract][Full Text] [Related]
9. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.
Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK
Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516
[TBL] [Abstract][Full Text] [Related]
10. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
[TBL] [Abstract][Full Text] [Related]
11. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
[TBL] [Abstract][Full Text] [Related]
12. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder.
Yun Y; Zhang Q; Zhao W; Ma T; Fan H; Bai L; Ma B; Qi S; Wang Z; An H; Yang F
J Psychosom Res; 2022 Dec; 163():111069. PubMed ID: 36335711
[TBL] [Abstract][Full Text] [Related]
14. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
Messaoud A; Mensi R; Douki W; Neffati F; Najjar MF; Gobbi G; Valtorta F; Gaha L; Comai S
World J Biol Psychiatry; 2019 Nov; 20(9):703-711. PubMed ID: 29683396
[No Abstract] [Full Text] [Related]
15. Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder.
Chou YH; Lirng JF; Hsieh WC; Chiu YC; Tu YA; Wang SJ
Eur Neuropsychopharmacol; 2016 Feb; 26(2):280-287. PubMed ID: 26706694
[TBL] [Abstract][Full Text] [Related]
16. Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study.
Hsu JW; Lirng JF; Wang SJ; Lin CL; Yang KC; Liao MH; Chou YH
Bipolar Disord; 2014 May; 16(3):241-8. PubMed ID: 24372850
[TBL] [Abstract][Full Text] [Related]
17. Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
Wang L; Yang P; Yang C; Yang D; Wu X; Cao T; Zeng C; Chen Q; Zhang S; Zhu Z; Jiao S; Cai H
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1283-1296. PubMed ID: 35410391
[TBL] [Abstract][Full Text] [Related]
18. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
19. Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study.
Colle R; Masson P; Verstuyft C; Fève B; Werner E; Boursier-Neyret C; Walther B; David DJ; Boniface B; Falissard B; Chanson P; Corruble E; Becquemont L
Psychiatry Clin Neurosci; 2020 Feb; 74(2):112-117. PubMed ID: 31599111
[TBL] [Abstract][Full Text] [Related]
20. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies.
Marx W; McGuinness AJ; Rocks T; Ruusunen A; Cleminson J; Walker AJ; Gomes-da-Costa S; Lane M; Sanches M; Diaz AP; Tseng PT; Lin PY; Berk M; Clarke G; O'Neil A; Jacka F; Stubbs B; Carvalho AF; Quevedo J; Soares JC; Fernandes BS
Mol Psychiatry; 2021 Aug; 26(8):4158-4178. PubMed ID: 33230205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
